Beta 2-microglobulin in chronic lymphocytic leukaemia

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Beta 2-microglobulin (S-beta 2 m) is a cell membrane protein linked to HLA-antigens.
• Its role in chronic lymphocytic leukemia (CLL) requires further investigation.

Purpose of the Study:

• To quantitate serum beta 2-microglobulin levels in CLL patients.
• To explore the correlation between S-beta 2 m levels and disease characteristics.

Main Methods:

• Serum beta 2-microglobulin levels were measured in 23 consecutive CLL patients.
• Tumor mass was estimated using Rai's clinical staging and peripheral lymphocyte counts.
• Lymphocyte proliferative activity was assessed via 3H-thymidine uptake in vitro.

Main Results:

• 10 out of 23 patients exhibited markedly elevated S-beta 2 m levels (>4.5 mg/L).
• Only 3 patients had normal S-beta 2 m values (<3.0 mg/L).
• High S-beta 2 m levels correlated significantly with larger tumor mass and higher lymphocyte counts.
• Elevated lymphocyte proliferation (3H-thymidine uptake) was observed in patients with the highest S-beta 2 m values.

Conclusions:

• Serum beta 2-microglobulin determination shows promise in assessing disease activity in CLL.
• Further long-term studies are needed to establish the clinical utility of S-beta 2 m in CLL management.